Cline Christopher R. sold TVTX
September 4, 2025 · Form 4 insider transaction
Cline Christopher R. sold 119 shares of Travere Therapeutics, Inc. at $19.71 per share, a transaction worth $2.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
119
Price
$19.71
Total value
$2.3K
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2025
Filing dateSeptember 5, 2025
Shares owned after92,083
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.